| Not Yet Recruiting | FLT3-ITD Targeted Therapy in Fit AML Patients AML (Acute Myeloid Leukemia) | Phase 2 / Phase 3 | 2026-12-01 |
| Not Yet Recruiting | A Randomized Phase II Study Evaluating Upfront SRT to All Brain Metastases Followed by Ivonescimab Plus Chemot Non Small Cell Lung Cancer | Phase 2 | 2026-04-01 |
| Not Yet Recruiting | Peri-operative Treatment of Resectable Gastroesophageal Cancer Using Bemarituzumab (BEMA) Plus Perioperative T GastroEsophageal Cancer | Phase 1 | 2026-02-20 |
| Recruiting | Vorasidenib Maintenance for IDH Mutant Astrocytoma IDH-mutant Grade 2 or 3 Astrocytoma | Phase 3 | 2026-01-16 |
| Not Yet Recruiting | Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer: an Open-label, S Non-Muscle Invasive Bladder Cancer | N/A | 2025-12-01 |
| Not Yet Recruiting | Radiopharmaceutical Treatment of Advanced Kidney Cancer Metastatic Clear Cell Renal Cell Carcinoma | Phase 2 | 2025-10-30 |
| Recruiting | Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer Oligometastatic Squamous Cell Carcinoma of the Head and Neck | Phase 3 | 2025-05-23 |
| Recruiting | Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors Prostate Cancer | Phase 3 | 2025-05-23 |
| Recruiting | OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction Breast Cancer, Prostate Cancer, NSCLC | N/A | 2025-04-15 |
| Recruiting | 177Lu-DOTATATE for Recurrent Meningioma Recurrent Meningioma | Phase 2 | 2025-03-10 |
| Not Yet Recruiting | Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer Bladder Cancer | Phase 2 | 2025-03-01 |
| Recruiting | Immunotherapy Consolidation After Radical Treatment of Synchronous Oligo-metastatic NSCLC NSCLC Stage IV | Phase 2 | 2025-01-14 |
| Not Yet Recruiting | Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Patient ER+ Breast Cancer, HER2-negative Breast Cancer, Breast Cancer Stage I | Phase 3 | 2024-12-01 |
| Recruiting | Adjuvant Tebentafusp in High Risk Ocular Melanoma Uveal Melanoma | Phase 3 | 2024-11-11 |
| Withdrawn | Simultaneous Care in Recurrent and/or Metastatic Head and Neck Cancer: the SupCare Study Head and Neck Neoplasms | N/A | 2024-09-01 |
| Recruiting | Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study First Progression of Glioblastoma | Phase 3 | 2024-03-15 |
| Withdrawn | Chemo-free BRCA-targeted Neoadjuvant Strategy TNBC - Triple-Negative Breast Cancer, BRCA1 Mutation, BRCA2 Mutation | Phase 2 | 2024-02-01 |
| Recruiting | Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA) ER-positive Breast Cancer, HER2-negative Breast Cancer, Stage IIB Breast Cancer | Phase 3 | 2023-12-15 |
| Suspended | Radiotherapy Plus Xevinapant in Older Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Locally Advanced Head and Neck Squamous Cell Carcinoma | Phase 2 | 2023-11-15 |
| Recruiting | Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-N Glioma, Glioneuronal Tumor, Choroid Plexus Tumor | — | 2023-03-21 |
| Recruiting | Anti-CCR4 Monoclonal Antibody (Mogamulizumab) and Total Skin Electron Beam Therapy (TSEB) in Patients With Sta Stage IB-IIB Cutaneous T-Cell Lymphoma | Phase 2 | 2023-03-07 |
| Terminated | Personalized Risk-Adapted Therapy in Post-Pubertal Patients With Newly-Diagnosed Medulloblastoma Medulloblastoma | Phase 2 | 2022-11-11 |
| Recruiting | PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Limited Stage Small Cell Lung Cancer, Extensive-stage Small-cell Lung Cancer | N/A | 2022-10-27 |
| Withdrawn | Phase II Trial of Romiplostim for Thrombocytopenia Induced by Lomustine at First Progression of MGMT Promoter- First Progression of MGMT Promoter-methylated Glioblastoma | Phase 2 | 2022-09-13 |
| Withdrawn | Pamiparib and Low Dose Temozolomide In Patients With Platinum Sensitive Biliary Tract Cancer Platinum-Sensitive Biliary Tract Cancer | Phase 2 | 2022-05-01 |
| Terminated | A 3 Arm Randomized Study on Health-related QoL of Elderly Patients With Advanced Soft Tissue Sarcoma Advanced Soft-tissue Sarcoma | Phase 3 | 2022-04-11 |
| Terminated | REACH: Study to Determine the Aetiology of Chlormethine Gel Induced-skin Drug Reaction in Early Stage Mycosis Early Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL) (Stage IA-IB) | Phase 2 | 2022-03-29 |
| Recruiting | Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE) Gynecologic Cancer, Skin Cancer, Head and Neck Cancer | N/A | 2021-06-10 |
| Withdrawn | Maintenance Immune Check-point Inhibitor Following Post-operative Chemo-radiation in Subjects With HPV-negativ Squamous Cell Head and Neck Carcinoma | Phase 3 | 2021-06-01 |
| Recruiting | Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma Retroperitoneal Sarcoma, Liposarcoma, Leiomyosarcoma | Phase 3 | 2021-01-20 |
| Withdrawn | Study of Photopheresis in the Treatment of Erythrodermic MF and SS Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides/Sezary Syndrome | Phase 2 | 2020-12-01 |
| Active Not Recruiting | Activity of Lorlatinib Based on ALK Resistance Mutations Detected on Blood in ALK Positive NSCLC Patients Non Small Cell Lung Cancer | Phase 2 | 2020-11-17 |
| Unknown | Follow-up in Early and Locally Advanced Breast Cancer Patients Breast Cancer | — | 2020-10-14 |
| Terminated | Dissecting the Pathways of Therapy Resistance in Early Breast Cancer Breast Cancer | — | 2020-07-08 |
| Withdrawn | Long-term Surival of GIST Patients ≥ 10 Years on Imatinib GIST | — | 2020-06-01 |
| Withdrawn | Lanreotide Combined With Telotristat Ethyl or Placebo for the First-line Treatment in Patients With Advanced W Small Intestinal NET, Carcinoid Heart Disease | Phase 3 | 2020-04-01 |
| Terminated | Trial in Low Grade Glioma Patients: Wait or Treat Low-grade Glioma, Temozolomide, Phase III | Phase 3 | 2020-03-16 |
| Withdrawn | Apalutamide With Radiotherapy and Androgen Deprivation Therapy in Prostate Cancer Prostate Cancer | Phase 3 | 2020-03-10 |
| Completed | Pembrolizumab in Biliary Tract Cancer Biliary Tract Cancer, Metastatic Cancer, Advanced Cancer | Phase 2 | 2020-01-07 |
| Withdrawn | Combination of Targeted and Immunotherapy for Advanced Biliary Tract and Esophagogastric Gastric Cancer Esophageal Cancer, Biliary Tract Cancer, GastroEsophageal Cancer | Phase 2 | 2019-12-01 |
| Terminated | Reduced Dose-density of Denosumab for Unresectable GCTB Bone Giant Cell Tumor | Phase 2 | 2019-09-26 |
| Active Not Recruiting | Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II Study Advanced Hodgkin Lymphoma | Phase 2 | 2019-08-01 |
| Active Not Recruiting | Postoperative Immunotherapy vs Standard Chemotherapy for Gastric Cancer With High Risk for Recurrence Gastric and Esophagogastric Junction Adenocarcinoma | Phase 2 | 2019-07-17 |
| Recruiting | E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe Cancer | — | 2019-06-24 |
| Active Not Recruiting | Adjuvant Palbociclib in Elderly Patients With Breast Cancer Breast Cancer Stage II, Breast Cancer Stage III | Phase 2 | 2019-06-14 |
| Unknown | Follow-up in Gynecological Cancer Survivors Gynecologic Cancer | — | 2019-02-21 |
| Terminated | Combination of Chemoradiation With Immunotherapy in Inoperable œsophageal Cancer Inoperable œsophageal Cancer | Phase 2 | 2019-01-17 |
| Completed | Synergism of Immunomodulation and Tumor Ablation Colorectal Cancer, Liver Metastases | Phase 2 | 2018-11-23 |
| Withdrawn | Combination of Durvalumab and Tremelimumab as Maintenance Treatment in Patients With Non Squamous and Squamous Squamous Non-small Cell Lung Cancer, Non-Squamous Non-small Cell Lung Cancer | Phase 2 | 2018-11-01 |
| Active Not Recruiting | Immunotherapy With Ipilimumab and Nivolumab Preceded or Not by a Targeted Therapy With Encorafenib and Binimet Unresectable Stage III Melanoma, Stage IV Melanoma | Phase 2 | 2018-10-30 |
| Terminated | PARCT: Trial of Atezolizumab in Relapsed/Refractory Cutaneous T Cell Lymphoma (CTCL) Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides/Sezary Syndrome | Phase 2 | 2018-09-24 |
| Completed | A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma Newly Diagnosed Glioblastoma | Phase 3 | 2018-07-26 |
| Completed | Multi-kinase Inhibitor TG02 (TG02) in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astro Astrocytoma, Grade III, Glioblastoma | Phase 1 | 2018-06-12 |
| Unknown | Nivolumab in Patients With Type B3 Thymoma and Thymic Carcinoma (NIVOTHYM) Thymoma Type B3, Thymic Carcinoma | Phase 2 | 2018-04-11 |
| Terminated | Nintedanib as Switch Maintenance Treatment of Pleural Malignant Mesothelioma Malignant Pleural Mesothelioma | Phase 2 | 2018-02-04 |
| Unknown | Imaging Biomarker in Cancer Drug Induced ILD Drug Induced Interstitial Lung Disease (DIILD) Cancer Patients | N/A | 2018-01-01 |
| Completed | Pembrolizumab in Untreated Extensive SCLC Small Cell Lung Cancer (SCLC) | Phase 2 | 2017-12-08 |
| Active Not Recruiting | ODM-201 vs Androgen Deprivation Therapy in Hormone naïve Prostate Cancer Prostate Cancer | Phase 2 | 2017-12-01 |
| Active Not Recruiting | Study Assessing The "Best of" Radiotherapy vs the "Best of" Surgery in Patients With Oropharyngeal Carcinoma Oropharyngeal Cancer, Supraglottic Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma | N/A | 2017-11-27 |
| Unknown | Biomarker-based Study in R/M SCCHN Carcinoma, Squamous Cell of Head and Neck | Phase 2 | 2017-11-16 |
| Terminated | Trabectedin Maintenance Post 1st-line in STS Sarcoma, Soft Tissue | Phase 3 | 2017-11-07 |
| Active Not Recruiting | Osimertinib Treatment on EGFR T790M Plasma Positive NSCLC Patients (APPLE) NSCLC | Phase 2 | 2017-10-10 |
| Active Not Recruiting | Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agon Prostate Cancer | Phase 3 | 2017-09-25 |
| Terminated | Ph II Nintedanib vs. Ifosfamide in Soft Tissue Sarcoma Sarcoma, Soft Tissue | Phase 2 | 2017-07-07 |
| Recruiting | SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access All Tumor Types | — | 2017-05-03 |
| Completed | Ph II CABOGIST in GIST Metastatic Gastrointestinal Stromal Tumor | Phase 2 | 2017-02-02 |
| Withdrawn | Lenvatinib in Second Line Endometrial Carcinoma Endometrial Neoplasms | Phase 2 | 2017-01-01 |
| Completed | Anti-programmed Cell Death-1 Ligand 1 (aPDL-1) Antibody Atezolizumab, Bevacizumab and Acetylsalicylic Acid in Ovarian Neoplasms | Phase 2 | 2016-12-23 |
| Withdrawn | Nintedanib Plus mFOLFOX6 for Previously Untreated Metastatic Esophagogastric Adenocarcinoma (MEGAN) Esophagogastric Adenocarcinoma, Metastatic Disease, No Previous Chemotherapy for Metastatic Esophagogastric Cancer | Phase 2 | 2016-12-01 |
| Completed | Diffusion-Weighted MRI for Liver Metastasis Colorectal Cancer, Colon Cancer Liver Metastasis, Malignant Neoplasm of Rectum Metastatic to Liver | — | 2016-11-01 |
| Unknown | Pleurectomy/ Decortication (P/D) Preceded or Followed by Chemotherapy in Patients With Early Stage MPM Malignant Pleural Mesothelioma | Phase 2 | 2016-09-20 |
| Withdrawn | A Phase II Clinical Trial of Chemo-radiotherapy in Combination With INO-3112 in Patients With Locally Advanced Uterine Cervical Neoplasms | Phase 2 | 2016-05-01 |
| Withdrawn | SPECTAbrain: Screening Patients With Brain Tumors for Efficient Clinical Trial Access Brain Neoplasms | — | 2016-05-01 |
| Suspended | Neoadjuvant Afatinib in Early Stage Non Small Cell Lung Cancer. Non Small Cell Lung Cancer | Phase 2 | 2016-01-01 |
| Unknown | Evaluation of FLT-PET and DWI-MRI in Patients With NSCLC Treated With a Platinum-based Doublet as Preoperative Non-small Cell Lung Carcinoma | N/A | 2015-10-01 |
| Active Not Recruiting | Phase III Radium 223 mCRPC-PEACE III Prostate Cancer | Phase 3 | 2015-10-01 |
| Completed | Androgen Deprivation Therapy in Advanced Salivary Gland Cancer Salivary Gland Cancer | Phase 2 | 2015-09-24 |
| Unknown | LungTech: Stereotactic Body Radiotherapy (SBRT) of Inoperable Centrally Located NSCLC Non-small Cell Lung Cancer Stage I, Non-small Cell Lung Cancer Stage II | Phase 2 | 2015-08-01 |
| Completed | Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Ade Malignant Neoplasm of Stomach, Malignant Neoplasm of Cardio-esophageal Junction of Stomach, Epidermal Growth Factor Receptor (EGFR) Protein Overexpression | Phase 2 | 2015-07-15 |
| Completed | Molecular Genetic, Host-derived and Clinical Determinants of Long-term Survival in Glioblastoma Glioblastoma | — | 2015-07-05 |
| Completed | Trabectedin for Recurrent Grade II/III Meningioma Recurrent High Grade Meningioma | Phase 2 | 2015-07-01 |
| Completed | SPECTAlung: Screening Patients With Thoracic Tumors for Efficient Clinical Trial Access Any Stage of Lung Cancer (Any Histotype), Any Stage of Malignant Pleural Mesothelioma, Any Stage of Any Thymic Malignancy | — | 2015-05-22 |
| Completed | A Prospective Colorectal Liver Metastasis Database With an Integrated Quality Assurance Program Liver Metastasis, Colorectal Carcinoma | — | 2015-05-01 |
| Completed | IRCI Gynae Sarcomas, High Grade Uterine Sarcoma Uterine Sarcoma | Phase 2 | 2015-02-02 |
| Unknown | Evaluation of Diffusion Weighted Imaging -MRI in Patients With Resectable Liver Metastases From Colorectal Can Liver Metastases, Colorectal Cancer | N/A | 2015-02-01 |
| Unknown | "InDACtion" vs "3+7" Induction in AML Acute Myeloid Leukemia (AML) | Phase 3 | 2014-11-28 |
| Completed | Cancer in Nursing Home Residents Armonea Nursing Homes Residents | — | 2014-10-01 |
| Completed | Ph II Cabazitaxel DD Liposarcoma Dedifferentiated Liposarcoma | Phase 2 | 2014-10-01 |
| Unknown | AF CRT +/- Nimorazole in HNSCC Locally Advanced Head and Neck HPV Negative Squamous Cell Cancers | Phase 3 | 2014-07-25 |
| Completed | Nintedanib(BIBF1120) in Thyroid Cancer Medullary Thyroid Cancer (MTC), Differentiated Thyroid Cancer (DTC) | Phase 2 | 2014-05-01 |
| Withdrawn | TAK-700 in Castration Resistant Prostate Cancer Prostate Cancer | Phase 2 | 2014-01-01 |
| Unknown | Genetics of EGFR (Epidermal Growth Factor Receptor) Mutation Study EGFR Mutation Positive Non Small Cell Lung Cancer | — | 2013-09-01 |
| Completed | Screening Platform for Clinical Trials in Advanced Colorectal Cancer Colorectal Cancer, Advanced Colorectal Cancer | — | 2013-09-01 |
| Completed | Elderly Metastatic Breast Cancer: Pertuzumab-Herceptin vs Pertuzumab-Herceptin-Metronomic Chemotherapy, Follow Elderly Metastatic Breast Cancer Population | Phase 2 | 2013-06-01 |
| Terminated | Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab in Patients With Resectable Live Colorectal Cancer Metastatic, Liver Metastases, KRAS Wild Type Colorectal Cancer | Phase 2 | 2013-06-01 |
| Withdrawn | Very Early FDG-PET/CT-response Adapted Therapy for Advanced Hodgkin Lymphoma (H11) Hodgkin Lymphoma | Phase 3 | 2013-05-01 |
| Terminated | Colorectal Cancer (CRC) Cetuximab Elderly Frail Colorectal Cancer Metastatic | Phase 2 | 2013-04-01 |
| Completed | Efficacy Study of Herceptin to Treat HER2-negative CTC Breast Cancer Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Circulating Tumor Cells | Phase 2 | 2013-04-01 |
| Withdrawn | Efficacy of FOLFOX Versus FOLFOX Plus Aflibercept in K-ras Mutant Patients With Resectable Liver Metastases Colorectal Cancer Metastatic, Liver Metastases, KRAS Mutated Colorectal Cancer | Phase 2 / Phase 3 | 2012-12-01 |
| Unknown | Adjuvant PEG Intron in Ulcerated Melanoma Ulcerated Melanomas | Phase 3 | 2012-10-01 |
| Completed | CREATE: Cross-tumoral Phase 2 With Crizotinib Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma, Locally Advanced and/or Metastatic Inflammatory Myofibroblastic Tumor, Locally Advanced and/or Metastatic Papillary Renal Cell Carcinoma Type 1 | Phase 2 | 2012-09-01 |
| Completed | Neoadjuvant Afatinib Window Study in Squamous Cell Carcinoma of the Head and Neck Carcinoma, Squamous Cell of Head and Neck | Phase 2 | 2012-07-01 |
| Completed | Pazopanib Hydrochloride, Paclitaxel, and Carboplatin in Treating Patients With Refractory or Resistant Ovarian Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 1 / Phase 2 | 2012-07-01 |
| Completed | Empirical Versus Preemptive Antifungal Therapy Fungal Infection, Leukemia, Myelodysplastic Syndromes | Phase 3 | 2012-03-01 |
| Completed | Surgery With or Without Radiation Therapy in Untreated Nonmetastatic Retroperitoneal Sarcoma Sarcoma | N/A | 2012-01-01 |
| Completed | Bevacizumab and Lomustine for Recurrent GBM Glioblastoma Multiforme, Cognition Disorders, Disability Evaluation | Phase 3 | 2011-10-01 |
| Terminated | Pazopanib Hydrochloride or a Placebo in Treating Patients With Non-Small Cell Lung Cancer Who Have Received Fi Lung Cancer | Phase 2 / Phase 3 | 2011-07-01 |
| Unknown | Study of Long-Term Outcomes of Patients With Acute Lymphoblastic Leukemia Who Were Enrolled as Children on Cli Cancer Survivor, Leukemia, Long-term Effects Secondary to Cancer Therapy in Children | — | 2011-07-01 |
| Unknown | Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic Leukemia Leukemia, Lymphoma | — | 2011-06-01 |
| Terminated | Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Sarcoma | Phase 2 / Phase 3 | 2011-05-01 |
| Completed | Bevacizumab in Recurrent Grade II and III Glioma Central Nervous System Tumors | Phase 2 | 2011-02-01 |
| Terminated | Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as Adenocarcinoma of the Gastroesophageal Junction, Gastric Cancer | Phase 2 | 2010-12-01 |
| Unknown | Male Breast Cancer: Understanding the Biology for Improved Patient Care Breast Cancer | — | 2010-12-01 |
| Terminated | Lenalidomide Maintenance Post-debulking in Advanced CTCL Lymphoma | Phase 3 | 2010-07-01 |
| Unknown | Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer Kidney Cancer | Phase 3 | 2010-04-01 |
| Terminated | Post-operative or Early Salvage XRT and ADT for High Risk PCa Prostate Cancer | Phase 3 | 2009-10-01 |
| Completed | Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Brain and Central Nervous System Tumors | Phase 2 | 2009-10-01 |
| Active Not Recruiting | Minimal SN Tumor Burden Cutaneous Melanoma | — | 2009-07-01 |
| Terminated | Imatinib Mesylate With or Without Surgery in Treating Patients With Metastatic Gastrointestinal Stromal Tumor Gastrointestinal Stromal Tumor | Phase 3 | 2009-05-01 |
| Terminated | Sunitinib Malate in Treating Patients With Small Cell Lung Cancer Lung Cancer | Phase 2 | 2009-02-01 |
| Unknown | Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndromes | Phase 1 / Phase 2 | 2008-11-01 |
| Completed | Chemotherapy and Radiation Therapy Before Surgery Followed by Capecitabine With or Without Oxaliplatin in Trea Colorectal Cancer | Phase 3 | 2008-08-01 |
| Terminated | Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III Head and Neck Cancer | Phase 2 | 2008-02-01 |
| Active Not Recruiting | Phase III Trial of Anaplastic Glioma Without 1p/19q Loss of Heterozygosity (LOH) Brain and Central Nervous System Tumors | Phase 3 | 2007-12-01 |
| Unknown | Radiation Therapy in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Grade II or Grade III Me Brain and Central Nervous System Tumors | Phase 2 | 2007-12-01 |
| Completed | Lapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastat Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter | Phase 1 | 2007-11-01 |
| Unknown | Enzastaurin and Temozolomide in Treating Patients With Primary Gliomas Brain and Central Nervous System Tumors | Phase 1 | 2007-07-01 |
| Completed | BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors Breast Cancer, Endometrial Cancer, Head and Neck Cancer | Phase 2 | 2007-07-01 |
| Completed | Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Adv Head and Neck Cancer | Phase 1 / Phase 2 | 2007-05-01 |
| Completed | Phase I/II Study of Neoadjuvant Lapatinib in Breast Cancer Breast Cancer | Phase 1 / Phase 2 | 2007-02-01 |
| Completed | Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma Malignant Mesothelioma | Phase 2 | 2007-02-01 |
| Completed | Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer Th Breast Cancer | Phase 3 | 2007-02-01 |
| Unknown | Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Res Colorectal Cancer, Metastatic Cancer | Phase 2 | 2007-01-01 |
| Completed | Epothilone ZK-219477 in Treating Patients With Recurrent Glioblastoma Brain and Central Nervous System Tumors | Phase 2 | 2006-12-01 |
| Completed | Lapatinib and Tamoxifen in Treating Patients With Advanced or Metastatic Breast Cancer Breast Cancer | Phase 1 | 2006-11-01 |
| Completed | Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors Breast Cancer, Colorectal Cancer, Gastric Cancer | — | 2006-11-01 |
| Unknown | Fludeoxyglucose F 18 PET Scan-Guided Therapy or Standard Therapy in Treating Patients With Previously Untreate Lymphoma | Phase 3 | 2006-10-01 |
| Unknown | Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastati Ovarian Cancer, Sarcoma, Small Intestine Cancer | Phase 2 | 2006-10-01 |
| Terminated | Pemetrexed Disodium and Cisplatin Before or After Surgery in Treating Patients With Stage IB or Stage II Non-S Lung Cancer | Phase 2 | 2006-08-01 |
| Completed | Erlotinib or Observation in Treating Patients Who Have Undergone First-Line Chemotherapy for Ovarian Cancer, P Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 3 | 2005-09-01 |
| Completed | Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignan Malignant Mesothelioma | Phase 2 | 2005-07-01 |
| Completed | Radiation Therapy or Temozolomide in Treating Patients With Gliomas Brain and Central Nervous System Tumors | Phase 3 | 2005-07-01 |
| Completed | Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Gliobla Brain and Central Nervous System Tumors | Phase 1 / Phase 2 | 2005-06-01 |
| Completed | Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Underg Cancer | — | 2005-02-01 |
| Completed | Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Unde Cancer | Phase 2 | 2005-02-01 |
| Terminated | Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastase Intraocular Melanoma, Metastatic Cancer | Phase 3 | 2005-01-01 |
| Completed | Gemcitabine, Cisplatin, and Gefitinib in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Lung Cancer | Phase 2 | 2004-12-01 |
| Completed | Imatinib Mesylate or Observation Only in Treating Patients Who Have Undergone Surgery for Localized Gastrointe Gastrointestinal Stromal Tumor | Phase 3 | 2004-12-01 |
| Terminated | Radiotherapy or Radiosurgery Compared With Observation Alone in Treating Patients With Newly Diagnosed, Benign Brain and Central Nervous System Tumors | Phase 3 | 2004-12-01 |
| Completed | NGR-TNF in Treating Patients With Advanced Solid Tumors Colorectal Cancer, Head and Neck Cancer, Kidney Cancer | Phase 1 | 2004-09-01 |
| Completed | Bortezomib, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorec Colorectal Cancer | Phase 1 | 2004-09-01 |
| Unknown | Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia Leukemia | Phase 2 / Phase 3 | 2004-06-01 |
| Unknown | Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery Melanoma (Skin) | Phase 2 | 2004-05-01 |
| Terminated | Gefitinib After Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Lung Cancer | Phase 3 | 2004-05-01 |
| Completed | Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme Brain and Central Nervous System Tumors | Phase 2 | 2004-05-01 |
| Completed | Docetaxel With or Without Oblimersen in Treating Patients With Hormone-Refractory Adenocarcinoma (Cancer) of t Prostate Cancer | Phase 2 | 2004-04-01 |
| Terminated | Boron Neutron Capture Therapy Using Boronophenylalanine-Fructose Complex in Treating Patients With Metastatic Melanoma (Skin) | Phase 2 | 2004-04-01 |
| Completed | Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Sarcoma | Phase 2 | 2004-04-01 |
| Completed | Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinom Colorectal Cancer | Phase 3 | 2004-03-01 |
| Unknown | Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas Brain and Central Nervous System Tumors | Phase 1 | 2004-03-01 |
| Completed | OSI-7904L and Oxaliplatin in Treating Patients With Refractory or Recurrent Advanced Colorectal Cancer Colorectal Cancer | Phase 1 | 2004-02-01 |
| Completed | Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients Wi Lymphoma, Small Intestine Cancer | Phase 2 | 2004-01-01 |
| Completed | Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Mye Leukemia, Myelodysplastic Syndromes | Phase 2 | 2003-11-01 |
| Completed | Infliximab in Treating Patients With Myelodysplastic Syndrome Myelodysplastic Syndromes | Phase 2 | 2003-10-01 |
| Completed | Liposomal Doxorubicin in Treating Patients With Stage IIB, Stage IVA, or Stage IVB Recurrent or Refractory Myc Lymphoma | Phase 2 | 2003-10-01 |
| Completed | Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/Neu-Overexpressing Stage IIIB, Stage II Breast Cancer | Phase 1 | 2003-08-01 |
| Terminated | Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer | Phase 2 / Phase 3 | 2003-07-01 |
| Completed | Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile Cancer Penile Cancer | Phase 2 | 2003-06-01 |
| Completed | Assessing Women's Attitudes About the Risk of Infertility Related to Adjuvant Therapy for Early Breast Cancer Breast Cancer, Psychosocial Effects of Cancer and Its Treatment, Sexual Dysfunction and Infertility | N/A | 2003-05-01 |
| Completed | Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer Colorectal Cancer | Phase 3 | 2003-05-01 |
| Completed | Gefitinib in Treating Patients With Metastatic Breast Cancer That Has Progressed After Antiestrogen and Nonste Breast Cancer | Phase 2 | 2003-05-01 |
| Completed | Anastrozole With or Without Gefitinib in Treating Postmenopausal Women With Metastatic or Locally Recurrent Br Breast Cancer | Phase 2 | 2003-05-01 |
| Completed | Gemcitabine and Radiation Therapy Compared With Gemcitabine Alone in Treating Patients Who Have Undergone Surg Pancreatic Cancer | Phase 2 / Phase 3 | 2003-05-01 |
| Completed | Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating P Colorectal Cancer, Head and Neck Cancer, Metastatic Cancer | Phase 1 | 2003-04-01 |
| Terminated | High-Dose 3-Dimensional Conformal Radiation Therapy in Treating Patients With Inoperable Stage I, Stage II, or Lung Cancer | Phase 1 | 2003-04-01 |
| Completed | Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metasta Sarcoma | Phase 3 | 2003-04-01 |
| Terminated | Combination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's Lymphoma Lymphoma | Phase 2 / Phase 3 | 2003-03-01 |
| Terminated | Ultraviolet Light Therapy Using Methoxsalen With or Without Bexarotene in Treating Patients With Mycosis Fungo Lymphoma | Phase 3 | 2003-01-01 |
| Completed | Gefitinib in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma Sarcoma | Phase 2 | 2002-10-01 |
| Completed | Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, a Endometrial Cancer | Phase 2 | 2002-09-01 |
| Completed | Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia Leukemia | Phase 3 | 2002-09-01 |
| Terminated | Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast Cancer Breast Cancer | Phase 2 / Phase 3 | 2002-09-01 |
| Completed | Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma | Phase 3 | 2002-08-01 |
| Completed | Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Carcinoma of Unknown Primary | Phase 3 | 2002-07-01 |
| Completed | Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed Duri Brain and Central Nervous System Tumors | Phase 1 | 2002-06-01 |
| Completed | Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma Gastrointestinal Stromal Tumor, Sarcoma | Phase 2 | 2002-05-01 |
| Completed | Study to Assess Cancer Patients' Satisfaction With Hospital Quality of Care Unspecified Adult Solid Tumor, Protocol Specific | — | 2002-05-01 |
| Completed | Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma Sarcoma | Phase 2 | 2002-05-01 |
| Unknown | Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic Syn Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms | Phase 3 | 2002-05-01 |
| Terminated | Chemotherapy With or Without Surgery in Treating Patients With Bladder Cancer Bladder Cancer | Phase 3 | 2002-05-01 |
| Terminated | Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases Colorectal Cancer, Metastatic Cancer | Phase 2 | 2002-05-01 |
| Terminated | Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer Chronic Myeloproliferative Disorders, Fever, Sweats, and Hot Flashes, Infection | N/A | 2002-04-01 |
| Completed | Assessing Quality of Life of Patients With Prostate Cancer Prostate Cancer | — | 2002-03-01 |
| Completed | Imatinib Mesylate in Treating Patients With Gliomas Brain and Central Nervous System Tumors | Phase 2 | 2002-03-01 |
| Completed | Combination Chemotherapy in Treating Older Patients With Non-Hodgkin's Lymphoma Lymphoma | Phase 2 | 2002-03-01 |
| Unknown | Chemotherapy Followed By Surgery Vs Radiotherapy Plus Chemotherapy in Patients With Stage IB or II Cervical Ca Cervical Cancer | Phase 3 | 2002-03-01 |
| Terminated | Vaccine Therapy in Treating Patients With Melanoma of the Eye Intraocular Melanoma | Phase 3 | 2002-02-01 |
| Completed | Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer Breast Cancer | Phase 2 | 2002-02-01 |
| Completed | Combination Chemotherapy in Treating Patients With Colorectal Cancer Colorectal Cancer | Phase 2 | 2002-02-01 |
| Completed | Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma Sarcoma | Phase 1 | 2001-11-01 |
| Completed | Radiation Therapy in Treating Patients With Aggressive Fibromatoses Desmoid Tumor | Phase 2 | 2001-11-01 |
| Terminated | Breast-Conserving Therapy Compared With Mastectomy Followed By Radiation Therapy in Treating Women With Locall Breast Cancer | Phase 3 | 2001-10-01 |
| Completed | Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cy Stage III Bladder Cancer, Stage IV Bladder Cancer, Transitional Cell Carcinoma of the Bladder | Phase 3 | 2001-10-01 |
| Terminated | Radiation Therapy and Fluorouracil Before Surgery in Treating Patients With Primary or Recurrent Bile Duct Can Extrahepatic Bile Duct Cancer, Liver Cancer | Phase 2 | 2001-10-01 |
| Completed | R101933 Combined With Chemotherapy in Treating Patients With Metastatic Breast Cancer That Has Not Responded t Breast Cancer | Phase 2 | 2001-09-01 |
| Completed | Radical Prostatectomy in Treating Patients With Locally Advanced Prostate Cancer Prostate Cancer | Phase 2 | 2001-09-01 |
| Completed | Halofuginone Hydrobromide in Treating Patients With Progressive Advanced Solid Tumors Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 2001-08-01 |
| Completed | MEN-10755 in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy Prostate Cancer | Phase 2 | 2001-08-01 |
| Terminated | Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Canc Drug/Agent Toxicity by Tissue/Organ, Head and Neck Cancer, Oral Complications | Phase 2 | 2001-07-01 |
| Completed | BCG With or Without Mitomycin in Treating Patients With Bladder Cancer Bladder Cancer | Phase 2 | 2001-06-01 |
| Completed | Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer Endometrial Cancer | Phase 2 | 2001-06-01 |
| Completed | Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer | Phase 3 | 2001-05-01 |
| Completed | Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer Head and Neck Cancer | Phase 2 | 2001-05-01 |
| Completed | Assessing Quality of Life of Patients With Stomach Cancer Gastric Cancer | — | 2001-04-01 |
| Completed | Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer Prostate Cancer | Phase 3 | 2001-04-01 |
| Terminated | Combination Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Stage IIIB Non-S Lung Cancer | Phase 2 | 2001-04-01 |
| Terminated | Temozolomide With or Without Radiation Therapy to the Brain in Treating Patients With Stage IV Melanoma That I Melanoma (Skin), Metastatic Cancer | Phase 3 | 2001-04-01 |
| Completed | Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treati Breast Cancer | Phase 3 | 2001-03-01 |
| Unknown | Chlorambucil in Treating Patients With Advanced Chronic Lymphocytic Leukemia Leukemia | Phase 3 | 2001-03-01 |
| Terminated | Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Head and Neck Cancer Head and Neck Cancer | Phase 3 | 2001-03-01 |
| Completed | Comparison of Complete Axillary Lymph Node Dissection With Axillary Radiation Therapy in Treating Women With I Breast Cancer | Phase 3 | 2001-02-01 |
| Completed | Radiation Therapy to Prevent Brain Metastases in Patients With Previously Treated Extensive-Stage Small Cell L Lung Cancer | Phase 3 | 2001-02-01 |
| Completed | Paclitaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Vulva Vulvar Cancer | Phase 2 | 2001-02-01 |
| Completed | Gemcitabine in Treating Patients With Recurrent or Metastatic Adenoid Cystic Cancer of the Head and Neck Head and Neck Cancer | Phase 2 | 2001-02-01 |
| Completed | E7070 in Treating Patients With Stage IV Melanoma Melanoma (Skin) | Phase 2 | 2001-02-01 |
| Terminated | Chemotherapy in Treating Patients With Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor Sarcoma | Phase 2 | 2001-01-01 |
| Completed | Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme Brain and Central Nervous System Tumors | Phase 2 | 2001-01-01 |
| Terminated | Involved-Field Radiation Therapy in Treating Patients With Previously Untreated Stage I or Stage II Low-Grade Lymphoma | Phase 3 | 2001-01-01 |
| Unknown | Imatinib Mesylate in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumor Gastrointestinal Stromal Tumor | Phase 3 | 2001-01-01 |
| Terminated | Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treati Prostate Cancer | Phase 3 | 2001-01-01 |
| Completed | Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer | Phase 2 / Phase 3 | 2001-01-01 |
| Terminated | ICI 182780 in Treating Women With Stage I or Stage II Primary Breast Cancer Breast Cancer | Phase 3 | 2000-11-01 |
| Unknown | Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Ca Colorectal Cancer, Metastatic Cancer | Phase 3 | 2000-09-01 |
| Completed | Mistletoe Lectin in Treating Patients With Refractory Advanced Solid Tumors Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 2000-09-01 |
| Terminated | Chemotherapy With or Without Surgery in Treating Patients With Recurrent Ovarian Cancer Ovarian Cancer | Phase 3 | 2000-08-01 |
| Completed | STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma Endometrial Cancer, Gastrointestinal Stromal Tumor, Ovarian Cancer | Phase 1 / Phase 2 | 2000-08-01 |
| Completed | Mistletoe Lectin in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 2000-08-01 |
| Completed | Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multifor Brain and Central Nervous System Tumors | Phase 3 | 2000-07-01 |
| Unknown | Interferon Alfa Following Surgery in Treating Patients With Stage III Melanoma Melanoma (Skin) | Phase 3 | 2000-06-01 |
| Completed | SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer | Phase 2 | 2000-06-01 |
| Completed | Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia Leukemia | Phase 2 | 2000-06-01 |
| Completed | Nitrocamptothecin in Treating Patients With Advanced Small Cell Lung Cancer Lung Cancer | Phase 2 | 2000-05-01 |
| Completed | Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer | Phase 2 | 2000-05-01 |
| Terminated | Oxaliplatin in Treating Women With Advanced or Metastatic Breast Cancer That Has Not Responded to Previous Che Breast Cancer | Phase 2 | 2000-05-01 |
| Completed | Nitrocamptothecin in Treating Patients With Advanced Ovarian Cancer Ovarian Cancer | Phase 2 | 2000-05-01 |
| Completed | Comparison of Two Regimens of Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer Breast Cancer | Phase 2 | 2000-04-01 |
| Completed | Docetaxel and Cisplatin in Treating Patients With Untreated Stage IIIA Non-small Cell Lung Cancer Lung Cancer | Phase 2 | 2000-03-01 |
| Completed | Nitrocamptothecin in Treating Patients With Glioblastoma Multiforme Brain and Central Nervous System Tumors | Phase 2 | 2000-03-01 |
| Completed | Combination Chemotherapy Before Surgery in Treating Women With Breast Cancer Breast Cancer | Phase 1 | 2000-02-01 |
| Completed | Glufosfamide With of Without Hydration in Treating Patients With Advanced Non-small Cell Lung Cancer Lung Cancer | Phase 2 | 2000-01-01 |
| Completed | MS 209 Plus Docetaxel in Treating Patients With Advanced Solid Tumors Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 1999-12-01 |
| Unknown | Vaccine Therapy in Treating Patients With Primary Stage II Melanoma Melanoma (Skin) | Phase 3 | 1999-12-01 |
| Completed | Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Solid Tumors Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 1999-12-01 |
| Completed | Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer Pancreatic Cancer | Phase 2 | 1999-12-01 |
| Completed | Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura Malignant Mesothelioma | Phase 3 | 1999-11-01 |
| Completed | Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed Malignant Mesothelioma | Phase 2 | 1999-11-01 |
| Completed | Acridine Carboxamide in Treating Patients With Recurrent Glioblastoma Multiforme Brain and Central Nervous System Tumors | Phase 2 | 1999-10-01 |
| Completed | Monoclonal Antibody Therapy Plus BCG in Treating Patients With Limited-Stage Small Cell Lung Cancer Lung Cancer | Phase 3 | 1999-09-01 |
| Unknown | Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute M Leukemia | Phase 3 | 1999-09-01 |
| Completed | Acridine Carboxamide in Treating Patients With Advanced Non-small Cell Lung Cancer Lung Cancer | Phase 2 | 1999-09-01 |
| Completed | Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locall Pancreatic Cancer | Phase 2 | 1999-07-01 |
| Terminated | Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer Gastric Cancer | Phase 3 | 1999-07-01 |
| Completed | Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal Cancer Colorectal Cancer | Phase 3 | 1999-07-01 |
| Completed | Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Cancer | Phase 3 | 1999-06-01 |
| Completed | Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma Lymphoma | Phase 3 | 1999-05-01 |
| Completed | Standard Radiation Therapy With or Without Stereotactic Radiation Therapy in Treating Patients With Glioma Brain and Central Nervous System Tumors | Phase 3 | 1999-04-01 |
| Withdrawn | CHS 828 in Treating Patients With Solid Tumors Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 1999-04-01 |
| Completed | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer Head and Neck Cancer | Phase 3 | 1999-04-01 |
| Completed | Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untre Mediastinal Cancer, Metastatic Cancer, Testicular Germ Cell Tumor | Phase 3 | 1999-04-01 |
| Terminated | Chemotherapy Plus Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell L Lung Cancer | Phase 3 | 1999-02-01 |
| Suspended | BIBX 1382 in Treating Patients With Solid Tumors Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 1999-02-01 |
| Withdrawn | Monoclonal Antibody Therapy in Treating Patients With Primary Myelodysplastic Syndrome Myelodysplastic Syndromes | Phase 2 | 1999-02-01 |
| Completed | Quality-of-Life Assessment in Patients With Ovarian Cancer Ovarian Cancer | — | 1999-01-01 |
| Completed | Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors Brain and Central Nervous System Tumors | Phase 2 | 1998-12-01 |
| Terminated | Combination Chemotherapy in Treating Children With Relapsed or Refractory Acute Lymphocytic Leukemia Leukemia | Phase 2 | 1998-12-01 |
| Unknown | Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lympho Leukemia, Lymphoma | Phase 3 | 1998-12-01 |
| Completed | Vinorelbine Plus Fluorouracil in Treating Women With Metastatic Breast Cancer Breast Cancer | N/A | 1998-12-01 |
| Unknown | Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia Leukemia | Phase 2 | 1998-12-01 |
| Active Not Recruiting | Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma Lymphoma | Phase 3 | 1998-10-01 |
| Terminated | Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder C Bladder Cancer | Phase 2 | 1998-10-01 |
| Unknown | Combination Chemotherapy in Treating Men With Germ Cell Cancer Extragonadal Germ Cell Tumor, Teratoma, Testicular Germ Cell Tumor | Phase 2 / Phase 3 | 1998-10-01 |
| Completed | Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tu Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 3 | 1998-09-01 |
| Withdrawn | KRN7000 in Treating Patients With Solid Tumors Lung Cancer, Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 1998-09-01 |
| Terminated | Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder C Bladder Cancer | Phase 2 | 1998-09-01 |
| Completed | Combination Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer Lung Cancer | Phase 3 | 1998-08-01 |
| Unknown | Amifostine With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome Anemia, Myelodysplastic Syndromes | Phase 2 | 1998-08-01 |
| Completed | ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unrese Lung Cancer, Melanoma (Skin) | Phase 2 | 1998-06-01 |
| Completed | E7070 in Treating Patients With Solid Tumors Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 1998-04-01 |
| Completed | Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors Brain and Central Nervous System Tumors | Phase 2 | 1998-04-01 |
| Completed | Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer Colorectal Cancer | Phase 3 | 1998-03-01 |
| Completed | E7070 in Treating Patients With Solid Tumors Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 1998-03-01 |
| Completed | Vaccination Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer Lung Cancer | Phase 3 | 1998-03-01 |
| Completed | Pelvic Drains After Radical Hysterectomy in Treating Patients With Uterine, Cervical, or Vaginal Cancer Cervical Cancer, Endometrial Cancer, Infection | Phase 3 | 1998-02-01 |
| Completed | Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Under Kidney Cancer | Phase 3 | 1998-02-01 |
| Completed | Quality-of-Life Assessment of Patients Who Have Cancer of the Esophagus Esophageal Cancer | — | 1998-02-01 |
| Completed | Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma Sarcoma | Phase 3 | 1998-01-01 |
| Completed | Radiation Therapy With or Without Chemotherapy After Surgery in Treating Patients With Stage IB or Stage IIA C Cervical Cancer | Phase 3 | 1997-12-01 |
| Completed | Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood C Bone Marrow Suppression, Fever, Sweats, and Hot Flashes, Infection | Phase 3 | 1997-11-01 |
| Completed | Interleukin-2 in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia Leukemia | Phase 2 | 1997-10-01 |
| Completed | Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma Lymphoma | Phase 2 | 1997-09-01 |
| Completed | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Primary CNS Lymphoma Lymphoma | Phase 2 | 1997-07-01 |
| Completed | Temozolomide in Patients With Progressive or Recurrent Non-small Cell Lung Cancer Lung Cancer | Phase 2 | 1997-07-01 |
| Completed | Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma Sarcoma | Phase 3 | 1997-07-01 |
| Completed | Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis Infection, Pulmonary Complications | Phase 3 | 1997-06-01 |
| Completed | MEN-10755 in Treating Patients With Solid Tumors Testicular Germ Cell Tumor, Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 1997-06-01 |
| Completed | Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas Pancreatic Cancer | Phase 3 | 1997-05-01 |
| Completed | MEN-10755 in Treating Adults With Recurrent or Refractory Solid Tumors Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 1997-04-01 |
| Completed | Hormone Therapy in Treating Patients With Advanced Prostate Cancer Prostate Cancer | Phase 3 | 1997-04-01 |
| Terminated | Chemotherapy Plus Interferon Alfa Alone or With Radiation Therapy and Peripheral Stem Cell Transplantation in Lymphoma | Phase 3 | 1997-03-01 |
| Completed | Surgery and BCG in Treating Patients With Bladder Cancer Bladder Cancer | Phase 3 | 1997-03-01 |
| Unknown | Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patie Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm | Phase 3 | 1997-03-01 |
| Completed | Paclitaxel in Treating Patients With Lung Cancer Lung Cancer | Phase 2 | 1997-01-01 |
| Unknown | Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelod Leukemia, Myelodysplastic Syndromes | Phase 3 | 1996-12-01 |
| Terminated | Adjuvant Radiation Therapy in Treating Patients With Brain Metastases Metastatic Cancer | Phase 3 | 1996-11-01 |
| Completed | Surgery and Vaccine Therapy in Treating Patients With Early Cervical Cancer Cervical Cancer | Phase 2 | 1996-11-01 |
| Completed | Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendrogl Brain and Central Nervous System Tumors | Phase 3 | 1996-08-01 |
| Unknown | Lymph Node Radiation Therapy in Patients With Stage I, Stage II, or Stage III Breast Cancer That Has Been Surg Breast Cancer | Phase 3 | 1996-07-01 |
| Completed | Combination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in Patients With Cancer of the Hypophar Head and Neck Cancer | Phase 3 | 1996-07-01 |
| Completed | Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer Breast Cancer | Phase 3 | 1996-05-01 |
| Completed | Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sa Endometrial Cancer, Kidney Cancer, Metastatic Cancer | Phase 3 | 1996-04-01 |
| Unknown | High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients Melanoma (Skin) | Phase 3 | 1996-04-01 |
| Completed | Interferon Alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney Cancer Kidney Cancer | Phase 3 | 1996-03-01 |
| Completed | Ecteinascidin 743 in Treating Adults With Advanced Solid Tumors Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 1996-02-01 |
| Completed | High-Dose Chemotherapy in Treating Patients With Advanced Stomach Cancer Gastric Cancer | Phase 2 | 1996-01-01 |
| Completed | Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia Leukemia, Neutropenia | Phase 3 | 1995-12-01 |
| Unknown | Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyeloc Leukemia | Phase 3 | 1995-10-01 |
| Completed | Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemi Leukemia, Lymphoma | Phase 3 | 1995-08-01 |
| Completed | Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer Extragonadal Germ Cell Tumor, Ovarian Cancer, Testicular Germ Cell Tumor | Phase 2 | 1995-07-01 |
| Completed | Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma Melanoma (Skin) | Phase 2 | 1995-06-01 |
| Completed | Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma Endometrial Cancer, Kidney Cancer, Ovarian Cancer | Phase 3 | 1995-02-01 |
| Completed | Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Lung Cancer | Phase 3 | 1994-12-01 |
| Completed | Radiation Therapy in Treating Patients With Brain Cancer Brain and Central Nervous System Tumors | Phase 3 | 1994-11-01 |
| Completed | High-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer Head and Neck Cancer | Phase 3 | 1994-02-01 |
| Unknown | Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients Leukemia | Phase 3 | 1993-11-01 |
| Active Not Recruiting | Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stag Lymphoma | Phase 3 | 1993-09-01 |
| Completed | Combination Chemotherapy and Surgery With or Without G-CSF in Treating Patients With Osteosarcoma Sarcoma | Phase 3 | 1993-08-01 |
| Completed | Radiation Therapy, Surgery, and Chemotherapy in Treating Patients With Rectal Cancer That Can Be Surgically Re Colorectal Cancer | Phase 3 | 1993-04-01 |
| Completed | Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic S Leukemia, Myelodysplastic Syndromes | Phase 3 | 1993-03-01 |
| Completed | Radiation Therapy Compared With No Further Treatment Following Surgery in Treating Patients With Prostate Canc Prostate Cancer | Phase 3 | 1992-12-01 |
| Completed | Strontium Compared With Radiation Therapy in Treating Patients With Hormone-Refractory Prostate Cancer With Pa Metastatic Cancer, Prostate Cancer | Phase 3 | 1992-10-01 |
| Completed | Kidney-Sparing Surgery Compared With Kidney Removal in Treating Patients With Kidney Cancer Kidney Cancer | Phase 3 | 1992-03-01 |
| Completed | Early Compared With Delayed Hormone Therapy in Treating Patients With Nonmetastatic Prostate Cancer Neoplasm, Prostate | Phase 3 | 1990-02-01 |
| Active Not Recruiting | RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease Lymphoma | Phase 3 | 1989-09-01 |
| Completed | Randomized Boost Versus no Boost Irradiation of Early Breast Cancer Breast Cancer | Phase 3 | 1989-05-01 |
| Completed | Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus Endometrial Cancer, Sarcoma | Phase 3 | 1988-04-01 |
| Completed | Radiation Therapy With or Without Goserelin and Cyproterone in Treating Patients With Prostate Cancer Prostate Cancer | Phase 3 | 1987-05-01 |
| Completed | A Randomized Phase III Study of Intensive Consolidation With High Dose Cytosine Arabinoside in Acute Myelogeno Leukemia | Phase 3 | 1986-11-01 |
| Withdrawn | Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery Head and Neck Cancer | Phase 3 | — |
| Withdrawn | SPECTAmel: Screening Patients With Melanoma Tumors for Efficient Clinical Trial Access Melanoma | — | — |
| Completed | Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma Brain and Central Nervous System Tumors, Endometrial Cancer, Gastrointestinal Stromal Tumor | Phase 2 | — |
| Withdrawn | Vorinostat With or Without Bortezomib in Treating Patients With Refractory or Recurrent Stage IIB, Stage III, Lymphoma | Phase 3 | — |